Edition:
United States

Xiangxue Pharmaceutical Co Ltd (300147.SZ)

300147.SZ on Shenzhen Stock Exchange

10.03CNY
--
Change (% chg)

-- (--)
Prev Close
¥10.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,362,565
52-wk High
¥15.00
52-wk Low
¥9.00

Chart for

About

XIANGXUE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the research, development, production and distribution of traditional Chinese medicines and herbal decoction pieces. The Company's main products include antiviral oral liquids, indigowoad root granules, Exocarpium Citri Reticulatae series Chinese... (more)

Overall

Beta: 0.90
Market Cap(Mil.): ¥6,634.61
Shares Outstanding(Mil.): 661.48
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.87 16.33
EPS (TTM): -- -- --
ROI: -- 15.11 14.66
ROE: -- 16.37 13.99

BRIEF-Xiangxue Pharmaceutical unit receives approval related to drug registration from MHRA

* Says unit Xiangcam TCM Research Centre Ltd received drug registration approval for Phynova Cold and Flu Relief Powder for Oral Solution, from MHRA(Medicines and healthcare products regulatory agency)

Aug 16 2017

BRIEF-Xiangxue Pharmaceutical gets regulatory approval for up to 1.2 bln yuan worth of bonds

* Says it gets securities regulator's approval for up to 1.2 billion yuan ($180.03 million) worth of bonds

Aug 11 2017

BRIEF-Xiangxue Pharmaceutical to invest 103 mln yuan in medical firm

* Says it will invest 103 million yuan into a medical firm, which is mainly engaged in investment, development and management of medical industry

Aug 01 2017

BRIEF-Xiangxue Pharmaceutical sees H1 FY 2017 net profit down 15 pct to up 5 pct

* Sees H1 FY 2017 net profit to decrease by 15 percent to increase by 5 percent, or to be 45.2 million yuan to 55.9 million yuan

Jul 17 2017

BRIEF-Xiangxue Pharmaceutical completes establishment of medical technology firm

* Says it completes establishment of medical technology firm with partners in Beijing city

Jun 19 2017

BRIEF-Xiangxue Pharmaceutical plans pharma subsidiary with investment of 10 mln yuan

* Says it plans to use 10 million yuan to set up a pharma subsidiary in Guangzhou

May 29 2017

BRIEF-Xiangxue Pharmaceutical unit to buy Chongqing-based medical firm from co for 2.6 mln yuan

* Says co's 51 percent owned Beijing-based pharmaceutical biotech unit plans to fully buy co's Chongqing-based medical unit at 2.6 million yuan

Apr 28 2017

BRIEF-Xiangxue Pharmaceutical unit to buy property in Wuhan at 167.3 mln yuan

* Says its unit enters into contract to buy a property (9574.05 square meter) located in Wuhan, at price of 167.3 million yuan

Apr 28 2017

BRIEF-Xiangxue Pharmaceutical issues 750 mln yuan super short-term debentures

* Says it issues 2017 first tranche super short-term debentures worth 750 million yuan with a term of 270 days and coupon rate of 5.6 percent

Mar 27 2017

BRIEF-Xiangxue Pharmaceutical sees Q1 FY 2017 net profit down 20 pct to 40 pct

* Sees Q1 FY 2017 net profit to decrease by 20 percent to 40 percent, or to be 18.9 million yuan to 25.2 million yuan

Mar 26 2017

Earnings vs. Estimates